Includes reviews of current clinical trial results and procedures for the relevant topics. Promotes a better understanding of cell therapy. Written by leading researchers in this exciting and rapidly advancing field. This book provides a wealth of insights, advances, and new perspectives on cell therapy for different types of neonatal ischemic disease, such as Hypoxic-Ischemic Encephalopathy (HIE), Periventricular Leukomalacia (PVL) and neonatal infarction. These diseases pose serious challenges for neonatologists and neurologists because the severe sequelae lead to decreasing QOL for patients and their families. The book develops new effective therapies combined with hypothermia therapy, an established treatment for HIE. After reviewing past approaches, it presents cutting-edge topics in cell therapy, one of the most promising candidates for treating neonatal ischemic disease.